Famed investor Michael Burry’s Scion Asset Management disclosed new bullish positions in Pfizer (PFE), Halliburton (HAL), Molina Healthcare (MOH), and Lululemon Athletica (LULU) in its latest quarterly regulatory filing.
The positions were disclosed in a 13F along with his bets against Nvidia (NVDA) and Palantir (PLTR).
The fund bought 6M call options on Pfizer (PFE) and 2.5M calls on Halliburton (HAL).
Burry’s bet on the healthcare company comes as investors hope for catalysts to boost the firm as it navigates post-COVID demand normalization. PFE was down 7.5% year-to-date.
Earlier in October, Halliburton (HAL) reported a steep drop in Q3 earnings that nevertheless topped analyst estimates, helped by steady demand for its drilling equipment. The company had also forecasted $400 million in annual savings from its cost-cutting measures. The firm is flat since the start of the year.
Scion also added 125K shares of Molina Healthcare (MOH), expanding exposure to managed care, and 100K shares of Lululemon Athletica (LULU). The former fell over 49% year-to-date, and the latter was down 56.7% since the start of the year.
Earlier in October, MOH significantly reduced its EPS guidance for 2025 due to the higher medical cost trend in all segments, which is disproportionately being felt in its marketplace business.
In addition, Scion added Bruker (BRKR) and SLM (SLM) to its portfolio, broadening exposure to scientific instrumentation and student-loan finance.